Lacey David L. 4
4 · Arcus Biosciences, Inc. · Filed Jun 16, 2022
Insider Transaction Report
Form 4
Lacey David L.
Director
Transactions
- Award
Common Stock
2022-06-14+4,100→ 42,452 total - Award
Stock Option (Right to Buy)
2022-06-14+16,800→ 16,800 totalExercise: $20.62Exp: 2032-06-13→ Common Stock (16,800 underlying)
Footnotes (3)
- [F1]Represents the grant of restricted stock units that vest in full on the earlier of June 14, 2023 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
- [F2]Includes 3,000 shares of restricted stock units (previously reported) that vested on June 3, 2022.
- [F3]The option will vest in full on the earlier of June 14, 2023 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control.